|
孙燕. 乳腺癌的综合治疗 [J]. 乳腺甲状腺外科, 2003(1):2.
|
|
Fisher B, Anderson S, Redmond C K. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer [J]. New England Journal of Medicine, 1995.1456.doi: 10.1056/NEJM199511303332203.
|
|
Fisher B, Jeong J H, Anderson S. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation [J]. New England Journal of Medicine, 2002(8):567.
|
|
Bonadonna G, Valagussa P, Moliterni A. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer the results of 20 years of follow-up [J]. New England Journal of Medicine, 1995, (14):901.doi: 10.1056/NEJM199504063321401.
|
|
Bonadonna G, Moliterni A, Zambetti M. 30 years follow up of randomized studies of adjuvant CMF in operable breast cancer, cohort study [J]. British Medical Journal, 2005, (7485):217.doi: 10.1136/bmj.38314.622095.8F.
|
|
Henderson I C, Berry D A, Demetri G D. Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer [J]. Journal of Clinical Oncology, 2003(6):976.
|
|
Mamounas E P, Bryant J, Lembersky B. Paclitaxel after doxorubicin plus cycolophosphamide as adjuvant chemotherapy for node-positive breast cancer:results from NSABP B-28 [J]. Journal of Clinical Oncology, 2005, (16):3686.doi: 10.1200/JCO.2005.10.517.
|
|
Fisher B, Brown A, Mamounas E. Effect of preoperative chemotherapy on local-regional in women with operable breast cancer:findings from NSABP B-18 [J]. Journal of Clinical Oncology, 1997(7):2483.
|
|
Fisher B, Redmond C K, Brown A. Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer:5 year results from the NSABP trial [J]. Journal of Clinical Oncology, 1986, (14):459.
|
|
ATAC Trialists' Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer [J]. Lancet, 2005.60.
|
|
Coates A S, keshaviah A, Thurlimann B. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer;update of study BIG1-98 [J]. Journal of Clinical Oncology, 2007.486.
|
|
Coombes R C, Kilburn L S, Snowdon C F. Survival and safety of exemestane versus tamoxifen after 2～3 years' tamoxifen treatment(Intergroup Exemestane Study)a randomized controlled trial [J]. LANCET, 2007, (9561):559.doi: 10.1016/S0140-6736(07)60200-1.
|
下载:
苏公网安备 32100302010246号